Citations

Clear

2391 citation(s) found for "Ma, Lin".

Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California
Banerjee, Ritu , Allen, Jennifer R. , Lin, S.-Y. Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela, Scott, Cheryl, Raftery, Ann, Mase, Sundari , Watt, James, Flood, Jennifer

Mayo Clinic

Journal of Clinical Microbiology | August 12, 2010 | Volume: 48 | Issue: 10 | Pages: 3779-3781

10.1128/jcm.01236-10 | PMID 20702667 Get It

ABSTRACTTo assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.
Use of Folic Acid–Containing Supplements after a Diagnosis of Colorectal Cancer in the Colon Cancer Family Registry
Holmes, Rebecca , Li, Lin , McKeown‐Eyssen, Gail, Haile, Robert W. , Potter, John D. , Figueiredo, Jane C. , Jenkins, Mark A. , Zheng, Yingye , Baron, John A. , Newcomb, Polly A. , Stern, Mariana Carla , Grady, William M. , Marchand, Loı̈c Le , Campbell, Peter T. , Limburg, Paul J. , Hopper, John L. , Ulrich, Cornelia M. , Jenkins, Mark A , Haile, Robert W , Potter, John D

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 9, 2010 | Volume: 19 | Issue: 8 | Pages: 2023-2034

10.1158/1055-9965.epi-09-1097 | PMID 20696661 Get It

AbstractBackground: Supplement use among cancer patients is high, and folic acid intake in particular may adversely affect the progression of colorectal cancer. Few studies have evaluated the use of folic acid–containing supplements (FAS) and its predictors in colorectal cancer patients.Objective: To assess the use of FAS, change in use, and its predictors after colorectal cancer diagnosis.Design: We used logistic regression models to investigate predictors of FAS use and its initiation after colorectal cancer diagnosis in 1,092 patients recruited through the Colon Cancer Family Registry.Results: The prevalence of FAS use was 35.4% before and 55.1% after colorectal cancer diagnosis (P = 0.004). Women were more likely than men to use FAS after diagnosis [odds ratio (OR), 1.47; 95% confidence interval (95% CI), 1.14-1.89], as were those consuming more fruit (Ptrend < 0.0001) or vegetables (Ptrend = 0.001), and U.S. residents (P < 0.0001). Less likely to use FAS after diagnosis were nonwhite patients (OR, 0.66; 95% CI, 0.45-0.97), current smokers (OR, 0.67; 95% CI, 0.46-0.96), and those with higher meat intake (Ptrend = 0.03). Predictors of FAS initiation after diagnosis were generally similar to those of FAS use after diagnosis, although associations with race and vegetable intake were weaker and those with exercise stronger.Conclusions: Our analysis showed substantial increases in the use of FAS after diagnosis with colorectal cancer, with use or initiation more likely among women, Caucasians, U.S. residents, and those with a health-promoting life-style.Impact: Studies of cancer prognosis that rely on prediagnostic exposure information may result in substantial misclassification. Cancer Epidemiol Biomarkers Prev; 19(8); 2023–34. ©2010 AACR.
Dyssynchrony Indices To Predict Response to Cardiac Resynchronization Therapy
Miyazaki, Chinami , Redfield, Margaret M. , Powell, Brian D. , Lin, Grace, Herges, Regina M., Hodge, David O. , Olson, Lyle J. , Hayes, David L. , Espinosa, Raúl E. , Rea, Robert F., Nelson, Susan M., Miller, Fletcher A., Oh, Jae K. , Bruce, Charles J.

Mayo Clinic

Circulation: Heart Failure | July 21, 2010 | Volume: 3 | Issue: 5 | Pages: 565-573

10.1161/circheartfailure.108.848085 | PMID 20647479 Get It

Background— Whether mechanical dyssynchrony indices predict reverse remodeling (RR) or clinical response to cardiac resynchronization therapy (CRT) remains controversial. This prospective study evaluated whether echocardiographic dyssynchrony indices predict RR or clinical response after CRT. Methods and Results— Of 184 patients with heart failure with anticipated CRT who were prospectively enrolled, 131 with wide QRS and left ventricular ejection fraction <35% had 6-month follow-up after CRT implantation. Fourteen dyssynchrony indices (feasibility) by M-mode (94%), tissue velocity (96%), tissue Doppler strain (92%), 2D speckle strain (65% to 86%), 3D echocardiography (79%), and timing intervals (98%) were evaluated. RR (end-systolic volume reduction ≥15%) occurred in 55% and more frequently in patients without (71%) than in patients with (42%) ischemic cardiomyopathy ( P =0.002). Overall, only M-mode, tissue Doppler strain, and total isovolumic time had a receiver operating characteristic area under the curve (AUC) greater than the line of no information, but none of these were strongly predictive of RR (AUC, 0.63 to 0.71). In nonischemic cardiomyopathy, no dyssynchrony index predicted RR. In ischemic cardiomyopathy, M-mode (AUC, 0.67), tissue Doppler strain (AUC, 0.79), and isovolumic time (AUC, 0.76) -derived indices predicted RR ( P <0.05 for all), although the incremental value was modest. No indices predicted clinical response assessed by Minnesota Living with Heart Failure Questionnaire, 6-minute walk distance, and peak oxygen consumption. Conclusions— These findings are consistent with the Predictors of Response to CRT study and do not support use of these dyssynchrony indices to guide use of CRT.
O1‐07‐01: Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggests a role for progranulin in successful aging
Ahmed, Zeshan, Sheng, Hong, Xu, Yafei , Lin, Wen-Lang, Innes, Amy, Yu, Xin , Hou, Harold, Yamanouchi, Keitaro, Petrucelli, Leonard , Nishihara, Masugi, Hutton, Michael , Lewis, Jada , Sheng, Hong, Chiba, Shuichi , McGowan, Eileen , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.249 Get It

O1‐04‐04: TDP‐43 mouse models: Tools toward understanding the normal and disease roles for TDP‐43
Lewis, Jada , Xu, Yafei , Zhang, Yongjie , Lin, Wen-Lang, Hutton, Mike, Petrucelli, Len, Cannon, Ashley , McGowan, Eileen , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2010.05.228 Get It

P1‐185: Wild‐type human TDP‐43 induces mitochondrial abnormalities and axonal degeneration in transgenic mice
Xu, Yafei , Lin, Wen-Lang, D’Alton, Simon , Sheng, Hong, Casey, Monica Castanedes, Tong, Jimei, Yu, Xin , Rademakers, Rosa , Hutton, Mike, Petrucelli, Leonard , Lewis, Jada , Gendron, Tania F. , Zhang, Yong‐Jie , Sheng, Hong, Crook, Richard , Knight, Joshua A. , Boylan, Khrista , McGowan, Eileen , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2010.05.735 Get It

Serum Cytokine Analysis in a Positive Chemoprevention Trial: Selenium, Interleukin-2, and an Association with Squamous Preneoplastic Disease
Roth, Mark J., Katki, Hormuzd A. , Wei, Wenqiang , Qiao, You‐Lin , Bagni, Rachel, Wang, Guo-Qing , Whitby, Denise , Dong, Zhi-Wei, Giffen, Carol , Gail, Mitchell H. , Limburg, Paul J. , Taylor, Philip R. , Dawsey, Sanford M. , Katki, Hormuzd A

Mayo Clinic

Cancer Prevention Research | June 30, 2010 | Volume: 3 | Issue: 7 | Pages: 810-817

10.1158/1940-6207.capr-09-0269 | PMID 20587703 Get It

Abstract This study represents a multiplex cytokine analysis of serum from a 10-month randomized, controlled trial of 238 subjects that investigated the effects of selenomethionine and/or celecoxib in subjects with mild or moderate esophageal squamous dysplasia. The original chemoprevention study found that, among those with mild dysplasia, selenomethionine treatment favorably altered dysplasia grade. The current analysis found that selenomethionine downregulated interleukin (IL)-2 by 9% (P = 0.04), whereas celecoxib downregulated IL-7 by 11% (P = 0.006) and upregulated IL-13 by 17% (P = 0.008). In addition, an increase in IL-7 tertile from baseline to t10 was significantly associated with an increase in dysplasia grade, both overall [odds ratio (OR), 1.47; P = 0.03] and among those with mild dysplasia at t0 (OR, 2.53; P = 0.001). An increase in IL-2 tertile from baseline to t10 was also nonsignificantly associated with worsening dysplasia for all participants (OR, 1.32; P = 0.098) and significantly associated with worsening dysplasia among those with mild dysplasia at baseline (OR, 2.0; P = 0.01). The association of increased IL-2 with worsening dysplasia remained significant in those on selenomethionine treatment who began the trial with mild dysplasia (OR, 2.52; P = 0.03). The current study shows that selenomethionine supplementation decreased serum IL-2 levels, whereas celecoxib treatment decreased IL-7 levels and increased IL-13 levels during a 10-month randomized chemoprevention trial. An increase in IL-2 or IL-7 was associated with increased severity of dysplasia over the course of the trial, especially in those who began the trial with mild dysplasia. The favorable effect of selenomethionine on esophageal dysplasia in the original trial may have been mediated in part by its effect in reducing the levels of IL-2. Cancer Prev Res; 3(7); 810–7. ©2010 AACR.
Confirmation of Linkage to and Localization of Familial Colon Cancer Risk Haplotype on Chromosome 9q22
Gray‐McGuire, Courtney, Guda, Kishore , Adrianto, Indra , Lin, Chee Paul , Natale, Leanna, Potter, John D. , Lindor, Noralane M. , Goode, Ellen L. , Jenkins, Robert B. , Jenkins, Mark A. , Young, Joanne , Buchanan, Daniel D. , Gallinger, Steve, Lewis, Susan, Elston, Robert C. , Markowitz, Sanford D. , Wiesner, Georgia L. , Newcomb, Polly A. , Poole, Elizabeth M. , Ulrich, Cornelia M. , Fridley, Brooke L. , Marchand, Loı̈c Le , Casey, Graham , Haile, Robert W. , Hopper, John L. , Adams, Mark , Lewis, Susan, Willis, Joseph , Buchanan, Daniel D , Jenkins, Mark A , Potter, John D

Mayo Clinic

Cancer Research | June 15, 2010 | Volume: 70 | Issue: 13 | Pages: 5409-5418

10.1158/0008-5472.can-10-0188 | PMID 20551049 Get It

Abstract Genetic risk factors are important contributors to the development of colorectal cancer. Following the definition of a linkage signal at 9q22-31, we fine mapped this region in an independent collection of colon cancer families. We used a custom array of single-nucleotide polymorphisms (SNP) densely spaced across the candidate region, performing both single-SNP and moving-window association analyses to identify a colon neoplasia risk haplotype. Through this approach, we isolated the association effect to a five-SNP haplotype centered at 98.15 Mb on chromosome 9q. This haplotype is in strong linkage disequilibrium with the haplotype block containing HABP4 and may be a surrogate for the effect of this CD30 Ki-1 antigen. It is also in close proximity to GALNT12, also recently shown to be altered in colon tumors. We used a predictive modeling algorithm to show the contribution of this risk haplotype and surrounding candidate genes in distinguishing between colon cancer cases and healthy controls. The ability to replicate this finding, the strength of the haplotype association (odds ratio, 3.68), and the accuracy of our prediction model (∼60%) all strongly support the presence of a locus for familial colon cancer on chromosome 9q. Cancer Res; 70(13); 5409–18. ©2010 AACR.
Relative Risk Estimated from the Ratio of Two Median Unbiased Estimates
Carter, Rickey E. , Lin, Yan , Lipsitz, Stuart R. , Hermayer, Kathie L., Newcombe, Robert Gordon , Carter, Rickey E

Mayo Clinic

Journal of the Royal Statistical Society Series C: Applied Statistics | June 10, 2010 | Volume: 59 | Issue: 4 | Pages: 657-671

10.1111/j.1467-9876.2010.00711.x | PMID 20711511 Get It

SummaryClinical trials often include binary end points. In some cases, no successes are observed and the usual large sample estimates of relative risk are undefined. The paper proposes an estimator for relative risk based on the median unbiased estimator. The relative risk estimator proposed is well defined and performs satisfactorily for a wide range of data configurations. To facilitate the use of the estimator, a deterministic bootstrap confidence interval is also proposed, and an SAS macro is available to perform the necessary calculations. An on-going randomized clinical trial motivated the development of the estimator and is used to illustrate the approach.
Human Airway Eosinophils Respond to Chemoattractants with Greater Eosinophil-Derived Neurotoxin Release, Adherence to Fibronectin, and Activation of the Ras–ERK Pathway When Compared with Blood Eosinophils
Bates, Mary Ellen , Sedgwick, Julie B., Liu, Lin Ying, Heuser, Rose G., Jarjour, Nizar N. , Kita, Hirohito , Bertics, Paul J., Fahy, John V. , Zhu, Yiming , Kita, H

Mayo Clinic

The Journal of Immunology | May 21, 2010 | Volume: 184 | Issue: 12 | Pages: 7125-7133

10.4049/jimmunol.0900634 | PMID 20495064 Get It

Abstract Human blood eosinophils exposed ex vivo to hematopoietic cytokines (e.g., IL-5 or GM-CSF) subsequently display enhanced responsiveness to numerous chemoattractants, such as chemokines, platelet-activating factor, or FMLP, through a process known as priming. Airway eosinophils, obtained by bronchoalveolar lavage after segmental Ag challenge, also exhibit enhanced responsiveness to selected chemoattractants, suggesting that they are primed during cell trafficking from the blood to the airway. Earlier work has shown that chemoattractants stimulate greater activation of ERK1 and ERK2 following IL-5 priming in vitro, thus revealing that ERK1/ERK2 activity can be a molecular readout of priming under these circumstances. Because few studies have examined the intracellular mechanisms regulating priming as it relates to human airway eosinophils, we evaluated the responsiveness of blood and airway eosinophils to chemoattractants (FMLP, platelet-activating factor, CCL11, CCL5, CXCL8) with respect to degranulation, adherence to fibronectin, or Ras–ERK signaling cascade activation. When compared with blood eosinophils, airway eosinophils exhibited greater FMLP-stimulated eosinophil-derived neurotoxin release as well as augmented FMLP- and CCL11-stimulated adherence to fibronectin. In airway eosinophils, FMLP, CCL11, and CCL5 stimulated greater activation of Ras or ERK1/ERK2 when compared with baseline. Ras activation by FMLP in blood eosinophils was also enhanced following IL-5 priming. These studies are consistent with a model of in vivo priming of eosinophils by IL-5 or related cytokines following allergen challenge, and further demonstrate the key role of priming in the chemoattractant-stimulated responses of eosinophils. These data also demonstrate the importance of the Ras–ERK signaling pathway in the regulation of eosinophil responses to chemoattractants in the airway. Human airway eosinophils respond to several chemoattractants with increased activation of the Ras–ERK cascade, eosinophil-derived neurotoxin release, and adherence to fibronectin relative to blood eosinophils.